Prelude Therapeutics, a clinical-stage precision oncology company, will participate in the Chardan Healthcare Conference in New York City on October 20, 2026. The company's Chief Scientific Officer and Chief Financial Officer will hold a fireside chat at 2:00 p.m. ET, which will be webcast live and archived for 90 days on Prelude's website. This event highlights Prelude's ongoing efforts in developing innovative cancer treatments, including selective KAT6A degraders and JAK2V617F mutant inhibitors. Investors and interested parties can access the presentation online to learn more about the company's progress and future plans.
Prelude Therapeutics' participation in the Chardan Healthcare Conference is presented here with a snapshot of Pluang's health sector market as of Oct 17, 2026 01:11 WIB: out of 150 US health stocks, only 25 rose while 124 fell. Among notable movers, GeneDx Holdings Corp (WGS) dropped 9.71% with 100% sell orders and a typical hold time of 20 days, contrasting with AbCellera Biologics Inc (ABCL) which fell 7.49% but saw 73% buy orders and a longer hold time of 41 days. Twist Bioscience Corp (TWST) also declined 8.31% with a mixed order activity leaning 63% sell and 37% buy over 27 days hold time.
Citigroup has raised its price target for Travelers to $395 following the company's strong third-quarter 2026 results, where core earnings per share reached $9.18, significantly surpassing analyst expectations. Travelers also improved its combined ra...
F.N.B. Corporation will report its Q3 2026 earnings on October 19, with analysts forecasting earnings of $0.43 per share, a 4.9% increase from last year. Revenue is expected to rise about 4% to around $476 million. Investors will focus on management'...
Nvidia's market value dropped by $200 billion following OpenAI's revenue run rate announcement, which came in $18 billion below expectations. This significant shortfall has sparked concerns among investors about the growth prospects of AI-related com...
Kuaishou Technology has officially launched Kling 4.0, its next-generation AI video generation model, focusing on improved stability in dynamic scenes, longer continuous video generation up to 30 seconds, and enhanced creative control with support fo...
Kuaishou Technology has officially launched Kling 4.0, the latest generation of its AI video creation model, focusing on realism, control, and professional quality. Kling 4.0 supports smoother large-scale motion, native single-pass generation of up t...
